(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

E EPIC PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

E EPIC PHARMA

ST13

US500000076716941

Class

5

Filing

76716941

Registration

5661666

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

05/27/2025

Trademark type

Combined

Nice classes

5

Filing date

09/25/2014

Registration date

01/22/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/27/2025

Last transaction

05/27/2025

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/30/2014

First use in commerce

06/30/2014

Drawing code

3

Owner type

16

Owner location

Laurelton, NY, US

Examiner

BLANE, SUZANNE

Current location

Historical data usage

Mark description

The mark consists of the wording "EPIC PHARMA" with "EPIC" in green capital letters above "PHARMA" in green capital letters. A circle design appears above the wording "EPIC" and consists of overlapping and crossing circle segments in varying shades of green inscribed in a circle in the center of which is a stylized letter "E" in white.

Holders and representatives

Holders

Epic Pharma, LLC

Representatives

Bruce L. Adams ADAMS & WILKS

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsanti-hypertension preparationsanti-depressantsurinary tract antispasm preparationsantihistaminesopioid analgesicsanti-hypoerkalemic preparationsanti-inflammatory preparationsblue acid or gallstone solubilizing preparations

Publications

History of USPTO decisions and trademark events.

52 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

05/27/2025

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

05/27/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/22/2025

ES8R

TEAS SECTION 8 RECEIVED

01/09/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/22/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/22/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/19/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/18/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/28/2018

IUAF

USE AMENDMENT FILED

11/26/2018

EISU

TEAS STATEMENT OF USE RECEIVED

11/26/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/26/2018

EX5G

SOU EXTENSION 5 GRANTED

05/25/2018

EXT5

SOU EXTENSION 5 FILED

05/23/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/23/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/23/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

11/28/2017

EX4G

SOU EXTENSION 4 GRANTED

11/24/2017

EXT4

SOU EXTENSION 4 FILED

11/24/2017

EEXT

SOU TEAS EXTENSION RECEIVED

11/24/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

06/02/2017

EX3G

SOU EXTENSION 3 GRANTED

06/01/2017

EXT3

SOU EXTENSION 3 FILED

05/24/2017

EEXT

SOU TEAS EXTENSION RECEIVED

05/24/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

11/25/2016

EX2G

SOU EXTENSION 2 GRANTED

11/23/2016

EXT2

SOU EXTENSION 2 FILED

11/23/2016

EEXT

SOU TEAS EXTENSION RECEIVED

11/23/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

06/09/2016

EX1G

SOU EXTENSION 1 GRANTED

06/08/2016

NOAC

CORRECTED NOA MAILED

05/25/2016

EXT1

SOU EXTENSION 1 FILED

05/24/2016

EEXT

SOU TEAS EXTENSION RECEIVED

05/24/2016

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/24/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/16/2016

MAIL

PAPER RECEIVED

02/29/2016

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

11/24/2015

PUBO

PUBLISHED FOR OPPOSITION

09/29/2015

NPUB

NOTICE OF PUBLICATION

09/09/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/24/2015

CNRT

NON-FINAL ACTION MAILED

08/24/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/22/2015

CNRT

NON-FINAL ACTION WRITTEN

08/22/2015

ACEC

AMENDMENT FROM APPLICANT ENTERED

08/04/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/04/2015

ALIE

ASSIGNED TO LIE

07/28/2015

MAIL

PAPER RECEIVED

07/20/2015

CNRT

NON-FINAL ACTION MAILED

01/15/2015

CNRT

NON-FINAL ACTION WRITTEN

01/14/2015

DOCK

ASSIGNED TO EXAMINER

01/14/2015

MAFR

APPLICATION FILING RECEIPT MAILED

10/03/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/29/2014

Continuous trademark protection

Get notified about every new filing that threatens E EPIC PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.